Massimo Colombo
Impact in
- Hepatology top 0.2%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Diseases and Immunity
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 85
- Hepatitis C virus research 71
- Liver Disease and Transplantation 12
- Hepatocellular Carcinoma Treatment and Prognosis 11
- Liver Diseases and Immunity 6
- Epidemiology 67
- Liver Disease Diagnosis and Treatment 52
- Hepatitis B Virus Studies 37
- Co-authors
- Maria Francesca DonatoAlessio AghemoMaria Grazia RumiMirella FraquelliCristina RigamontiG. RonchiGiovanni CasazzaD. Conte
- Journals
- Journal of Hepatology (12 papers)Gastroenterology (7 papers)Hepatology (7 papers)Digestive and Liver Disease (6 papers)Liver International (6 papers)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Massimo Colombo
97 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Hepatology 3.2k
- Epidemiology 3.2k
- Transplantation 70
- Infectious Diseases 452
- Hematology 148
Countries citing papers authored by Massimo Colombo
This map shows the geographic impact of Massimo Colombo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Colombo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Colombo more than expected).
Fields of papers citing papers by Massimo Colombo
This network shows the impact of papers produced by Massimo Colombo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Colombo. The network helps show where Massimo Colombo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Massimo Colombo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 79 | |
| 3 | 2021 | 8 | |
| 4 | 2021 | 2 | |
| 5 | 2020 | 1 | |
| 6 | 2020 | 5 | |
| 7 | OUTCOMES OF PATIENTS INTERRUPTING GLECAPREVIR/PIBRENTASVIR TREATMENT: A CASE SERIES FROM CLINICAL TRIALS | 2019 | 2 |
| 8 | 2019 | 3 | |
| 9 | 2019 | 15 | |
| 10 | 2017 | 4 | |
| 11 | ENDURANCE-4: Efficacy and Safety of ABT-493/ABT-530 Treatment in Patients with Chronic HCV Genotype 4, 5, or 6 Infection | 2016 | 7 |
| 12 | 2014 | 1 | |
| 13 | 2014 | 24 | |
| 14 | 2014 | 34 | |
| 15 | 2013 | 111 | |
| 16 | 2010 | 108 | |
| 17 | 2008 | 15 | |
| 18 | The natural history of hepatitis C virus infection in Italian patients with von Willebrand's disease: a cohort study. | 2006 | 18 |
| 19 | 2001 | 15 | |
| 20 | 1997 | 47 |
About Massimo Colombo
Massimo Colombo is a scholar working on Hepatology, Epidemiology, Rheumatology, Infectious Diseases and Hematology, having authored 98 papers that have together received 4.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (71 papers), Liver Disease Diagnosis and Treatment (52 papers), Hepatitis B Virus Studies (37 papers), Liver Disease and Transplantation (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Systemic Lupus Erythematosus Research (10 papers), HIV/AIDS drug development and treatment (7 papers) and Liver Diseases and Immunity (6 papers). The work is most often cited by research in Hepatology (3.2k citations), Epidemiology (3.2k citations), Transplantation (70 citations), Infectious Diseases (452 citations) and Hematology (148 citations). Massimo Colombo has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Maria Francesca Donato, Alessio Aghemo, Maria Grazia Rumi, Mirella Fraquelli, Cristina Rigamonti, G. Ronchi, Giovanni Casazza, D. Conte, Roberta D’Ambrosio and Valérie Paradis. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Hepatology, Digestive and Liver Disease and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.